# Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense)

> **NCT03008239** · NA · UNKNOWN · sponsor: **Lee's Pharmaceutical Limited** · enrollment: 26 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DEVICE:** FiberSense sensor
- **DEVICE:** Dexcom Sensor

## Key facts

- **NCT ID:** NCT03008239
- **Lead sponsor:** Lee's Pharmaceutical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-14
- **Primary completion:** 2019-07-10
- **Final completion:** 2019-10
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2019-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03008239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03008239, "Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03008239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*